Beta Bionics Inc BBNX

US Health Care

$12.83 ▼ -10.09% ($-1.44)

⬇️ Below Yest. Low 🔥 High Short Interest

Open $13.99

Prev Close $14.27

Day Range $12.79 – $14.28

52W Range $8.80 – $32.71

Market Cap $577.22M

Beta 0.50

EPS (TTM) $-1.51

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2025-01-30
Shares Out.	44,990,000
Website	betabionics.com ↗
Phone	18002462677
Employees	423
Revenue	$32.0M
Gross Profit	$18.9M
Net Income	-$23.4M
Free Cash Flow	-$61.4M
Total Assets	$292.4M
Total Liabilities	$36.0M
Equity	$256.4M

About Beta Bionics Inc

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Beta Bionics Inc is a publicly traded company under the ticker symbol BBNX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.